Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 5 Issue 4

Synergistic Compositions of Traditional Medicine (SIDDHA) against Perilous +ssRNA Coronavirus a Future Alternative Medicine - A Mini Review

King Solomon Ebenezer1,2*, Chidambaram Tamilselvan1, Rekha Manivanan2, Sundaram Ravikumar3 and Pandi Boomi4

1Drug Testing Laboratory, Bioscience Research Foundation, Chennai, Tamilnadu, India
2Department of Toxicology, Bioscience Research Foundation, Chennai, Tamilnadu, India
3Department of Biomedical Science, Alagappa University, Karaikudi, Tamilnadu, India
4Department of Bioinformatics, Alagappa University, Karaikudi, Tamilnadu, India

*Corresponding Author: King Solomon Ebenezer, Bioscience Research Foundation, Chennai, India.

Received: December 17, 2020; Published: March 20, 2021



Siddha medicinal system is an admirable ancient symbol of Tamil culture and used from time immemorial in India which is originated in Tamil Nadu and invented from Dravidian culture by the Siddhars (Tamil sages). Globally, siddha drugs are considered to be an important alternative to modern allopathic drugs, also the siddha product and research is very popular for the drug discovery process. The siddha medicinal system is well versed in treating diseases, even incurable by the allopathic practitioners, but their mode of action remained a mystery all these years resulting in their unpopularity in the modern world. The recent alarming rise of novel deadly viral infections in the society demands novel drugs for treatment and made the researchers looking into the alternative therapies. Hence, recently many researchers are forthcoming in evaluating the antiviral activity of the siddha drugs using modern scientific approaches. In context to this, this mini review summarizes the synergistic compositions of siddha drugs and their efficacy against pathogenic single strand positive sense RNA coronavirus disease.

Keywords: Corona Virus; Siddha; Drugs; Traditional Medicine; Alternative Medicine



  1. Stephen ES. “Complementary and alternative medicine”. In: Dennis LK, Eugene B, Anthony SF, Stephen LH, Llarry JL, editors. Harrisons Principles of internal medicine. 16th ed, McGraw-Hill Medical Publishing Division; (2005): 67.
  2. Gogtay N., et al. “The Use and Safety of Non-Allopathic Indian Medicines”. Drug-Safety (2002): 25, 1005-1019.
  3. Richard S Weiss “Recipes for Immortality: Healing, Religion, and Community in South India: Healing, Religion, and Community in South India”. Oxford University Press (2009).
  4. Karemore MN and Avari JG. “Herbal medicines used during pregnancy, childbirth and postpartum care”. International Journal of Pharmaceutical Sciences and Research 12 (2012): 5326-5335.
  5. Cui J., et al. “Origin and evolution of pathogenic coronaviruses”. Nature Reviews Microbiology 17 (2019): 181-192.
  6. Indranil Chakraborty and Prasenjit Maity. “COVID-19 outbreak: Migration, effects on society, global environment and prevention”. Science of The Total Environment 728 (2020): 138882
  7. Fang Jiang., et al. “Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)”. Journal of General Internal Medicine 35 (2020): 1545-1549.
  8. Muhammad Adnan Shereen., et al. “COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses”. Journal of Advanced Research 24 (2020): 91-98.
  9. De Groot RJ. “Family Coronaviridae”. Virus Taxon, ICTV (2012): 806-820.
  10. Linda J Saif. “Coronavirus Immunogens”. Veterinary Microbiology 3-4 (1993): 285-297.
  11. Nour Ramadan and Houssam Shaib. “Middle east respiratory syndrome coronavirus (MERS-CoV): A review”. Germs1 (2019): 35-42.
  12. Jasper FW Chan., et al. “Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?” Journal of Infection 65 (2012): 477-89.
  13. Yang Y., et al. “Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis”. Fitoterapia 92 (2014): 133-147.
  14. Sharma PV and Siddha medicine. “In History of Medicine in India” (Ed.) P. V. Sharma. New Delhi: The Indian National Science Academy (1992): 445-45.
  15. Muthukumar NJ., et al. “Physico Chemical And Phytochemical Analysis Of Vishnu Chakra Mathirai -A Siddha Herbo Mineral Formalation”. Indian Journal of Research6 (2016): 204-207:
  16. Jaspreet Jain., et al. “Standardization of in vitro assays to evaluate the activity of polyherbal siddha formulations against Chikungunya virus infection”. Virus Disease1 (2018): 32-39.
  17. Anbarasu K., et al. “Antipyretic, anti-inflammatory and analgesic properties of Nilavembu kudineer choornam: a classical preparation used in the treatment of chikungunya fever”. Asian Pacific Journal of Tropical Medicine (2011): 819-823.
  18. Caceres DD., et al. “Prevention of common colds with Andrographis paniculata dried extract. A pilot double blind trial”. Phytomedicine2 (1997): 101-104.
  19. Christian GJ., et al. “Protective Effect of Polyherbal Siddha Formulation-Nilavembu Kudineer against Common Viral Fevers Including Dengue - A Case-Control Approach”. International Journal of Pharmaceutical Sciences and Research 4 (2015).
  20. Mishra LC., et al. “Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review”. Alternative Medicine Review 5 (2000): 334-346.
  21. Jaspreet Jain., et al. “In Vivo Evaluation of Withania somnifera Based Indian Traditional Formulation (Amukkara Choornam), Against Chikungunya Virus-Induced Morbidity and Arthralgia”. Journal of Evidence Based Integrative Medicine 23 (2018): 1-7.
  22. Vareed, SK., et al. “Blood-brain barrier permeability of bioactive with an amides present in Withania somnifera fruit extract”. Phytotheraphy Research 28 (2014): 1260-1264.
  23. Pitchiah Kumar M., et al. “Coronavirus Spike (S) Glycoprotein (2019-Ncov) Targeted Siddha Medicines Kabasura Kudineer and Thonthasura Kudineer -In silico Evidence for Corona Viral Drug”. Asian Journal of Pharmaceutical Research and Health Care2 (2019): 1-9.
  24. Anti-Inflammatory, Antipyretic And Antibacterial Study Of Kabasura Kudineer Choornam (2017).
  25. Gangarapu Kiran L., et al. “In Silico computational screening of Kabasura Kudineer- Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein”. Journal of Ayurveda and Integrative Medicine 11 (2020): 1-2.
  26. Murugesan Mudaliar and KS Gunapadam “Porut panbu Nool- Part - 1, Moligai Vagupu”, 7th ed, Department of Indian Medicine and Homeopathy. Government of Tamil Nadu, Chennai (2003).
  27. Alexandra C Walls., et al. “Structure, Function and Antigenicity of the SARS-CoV-2 Spike Glycoprotein”. Cell 2 (2020): 281-296.
  28. Kalai arasi R., et al. “Combination Of Nilavembu Kudineer And Adathodai Manapagu In The Management Of Dengue Fever”. International Journal of Current Research4 (2013): 978-981.
  29. Karthikeyen Lakshmanan., et al. “Screening of Kabasura Kudineer Chooranam against COVID-19 through targeting of main protease and RNA-dependent RNA polymerase of SARS-Cov-2 by molecular docking studies”. (2020).


Citation: King Solomon Ebenezer., et al. “Synergistic Compositions of Traditional Medicine (SIDDHA) against Perilous +ssRNA Coronavirus a Future Alternative Medicine - A Mini Review". Acta Scientific Pharmaceutical Sciences 5.4 (2021): 55-66.


Acceptance rate32%
Acceptance to publication20-30 days
Impact Factor0.759

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 25, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US